| George C Hsu, DO | |
|
1351 E Spruce Ave, Fresno, CA 93720 | |
| (559) 432-3300 | |
| Not Available |
| Full Name | George C Hsu |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 19 Years |
| Location | 1351 E Spruce Ave, Fresno, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881801157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 20A11211 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Clovis Community Medical Center | Clovis, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Calif Ent Medical Group | 6901853316 | 17 |
News Archive
As the COVID-19 pandemic lingers, researchers have found associations between certain lifestyle factors and a person's risk of getting infected.
Patients and families who are dealing with conditions such as non-healing wounds, bedsores, bladder and bowel incontinence and ostomy-related issues contend with physical symptoms, as well as social and emotional side effects. The impact on patients and families can exact an enormous toll. The Wound Ostomy & Continence Nurses Society is launching a campaign to raise awareness about the benefits of specialized care.
The largest trial so far conducted using Butterbur extract to treat intermittent allergic rhinitis (hay fever) shows that this plant extract is as effective as a commonly used antihistamine (Telfast 180).
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval of ADCETRIS (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare for the treatment of patients with CD30-positive relapsed or refractory Hodgkin lymphoma and anaplastic large cell lymphoma.
› Verified 2 days ago
| Entity Name | Central Calif Ent Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083673842 PECOS PAC ID: 6901853316 Enrollment ID: O20050406001264 |
News Archive
As the COVID-19 pandemic lingers, researchers have found associations between certain lifestyle factors and a person's risk of getting infected.
Patients and families who are dealing with conditions such as non-healing wounds, bedsores, bladder and bowel incontinence and ostomy-related issues contend with physical symptoms, as well as social and emotional side effects. The impact on patients and families can exact an enormous toll. The Wound Ostomy & Continence Nurses Society is launching a campaign to raise awareness about the benefits of specialized care.
The largest trial so far conducted using Butterbur extract to treat intermittent allergic rhinitis (hay fever) shows that this plant extract is as effective as a commonly used antihistamine (Telfast 180).
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval of ADCETRIS (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare for the treatment of patients with CD30-positive relapsed or refractory Hodgkin lymphoma and anaplastic large cell lymphoma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| George C Hsu, DO 1351 E Spruce Ave, Fresno, CA 93720-3342 Ph: (559) 432-3303 | George C Hsu, DO 1351 E Spruce Ave, Fresno, CA 93720 Ph: (559) 432-3300 |
News Archive
As the COVID-19 pandemic lingers, researchers have found associations between certain lifestyle factors and a person's risk of getting infected.
Patients and families who are dealing with conditions such as non-healing wounds, bedsores, bladder and bowel incontinence and ostomy-related issues contend with physical symptoms, as well as social and emotional side effects. The impact on patients and families can exact an enormous toll. The Wound Ostomy & Continence Nurses Society is launching a campaign to raise awareness about the benefits of specialized care.
The largest trial so far conducted using Butterbur extract to treat intermittent allergic rhinitis (hay fever) shows that this plant extract is as effective as a commonly used antihistamine (Telfast 180).
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval of ADCETRIS (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare for the treatment of patients with CD30-positive relapsed or refractory Hodgkin lymphoma and anaplastic large cell lymphoma.
› Verified 2 days ago
Richard A Weinberg, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1351 E Spruce Ave, Fresno, CA 93720 Phone: 559-432-3303 Fax: 559-432-1468 | |
Brian James Baumgartner, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2615 E Clinton Ave # 112, Fresno, CA 93703 Phone: 559-225-6100 Fax: 559-228-5309 | |
Dr. Jennifer N Davies, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1351 E Spruce Ave, Fresno, CA 93720 Phone: 559-432-3303 Fax: 559-432-1468 | |
Mr. Ronaldo A Ballecer, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 540 E Herndon Ave Ste 105, Suite 105, Fresno, CA 93720 Phone: 559-432-5154 Fax: 559-432-8763 | |
Allen M Evans, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1351 E Spruce Ave, Fresno, CA 93720 Phone: 559-432-3303 Fax: 559-432-1468 | |
Dr. Brien Windus Tonkinson, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1351 E Spruce Ave, Fresno, CA 93720 Phone: 559-432-3303 | |
Bret Edward Sherman, M.D., PH.D., F.A.C.S Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 540 E Herndon Ave Ste 101, Fresno, CA 93720 Phone: 559-431-0340 Fax: 559-431-0301 |